|
|
|
Insider
Information: |
Brennan Daniel J. |
Relationship: |
Director |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
272,248 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,876,916 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
272,248 |
|
|
Total
Value |
$18,876,916 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
2.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-20 |
4 |
S |
$65.86 |
$899,779 |
D/D |
(13,662) |
271,542 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-20 |
4 |
OE |
$13.08 |
$178,699 |
D/D |
13,662 |
285,204 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-18 |
4 |
D |
$65.82 |
$108,208 |
D/D |
(1,644) |
271,542 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
273,186 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,583 |
271,513 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-17 |
4 |
D |
$65.82 |
$133,812 |
D/D |
(2,033) |
269,480 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-16 |
4 |
D |
$65.82 |
$123,873 |
D/D |
(1,882) |
266,930 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,243 |
268,812 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-14 |
4 |
D |
$65.95 |
$127,613 |
D/D |
(1,935) |
264,569 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,362 |
266,504 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,262) |
262,142 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
278,404 |
0 |
- |
|
WAT |
Waters Corp |
Director |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
334 |
706 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-01-01 |
4 |
D |
$57.81 |
$473,984 |
D/D |
(8,199) |
241,738 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,979 |
249,937 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-03-02 |
4 |
AS |
$46.66 |
$1,399,914 |
D/D |
(30,000) |
225,958 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-03-01 |
4 |
AS |
$46.64 |
$3,526,337 |
D/D |
(75,610) |
255,958 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-03-01 |
4 |
OE |
$13.08 |
$715,794 |
D/D |
45,610 |
331,568 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-21 |
4 |
D |
$46.23 |
$75,078 |
D/D |
(1,624) |
285,958 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,661 |
287,582 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,706 |
285,565 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-18 |
4 |
D |
$46.54 |
$76,512 |
D/D |
(1,644) |
283,921 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-17 |
4 |
D |
$46.54 |
$94,616 |
D/D |
(2,033) |
281,859 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,583 |
283,892 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-16 |
4 |
D |
$46.48 |
$58,100 |
D/D |
(1,250) |
279,309 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|